跨界和新发疾病 SCIE

期刊简介估量审稿时候： 较慢,18-36周

Transboundary and Emerging Diseases brings together in one place the latest research on infectious diseases considered to hold the greatest economic threat to animals and humans worldwide. The journal provides a venue for global research on their diagnosis, prevention and management, and for papers on public health, pathogenesis, epidemiology, statistical modeling, diagnostics, biosecurity issues, genomics, vaccine development and rapid communication of new outbreaks. Papers should include timely research approaches using state-of-the-art technologies. The editors encourage papers adopting a science-based approach on socio-economic and environmental factors influencing the management of the bio-security threat posed by these diseases, including risk analysis and disease spread modeling. Preference will be given to communications focusing on novel science-based approaches to controlling transboundary and emerging diseases. The following topics are generally considered out-of-scope, but decisions are made on a case-by-case basis (for example, studies on cryptic wildlife populations, and those on potential species extinctions):

Pathogen discovery: a common pathogen newly recognised in a specific country, or a new pathogen or genetic sequence for which there is little context about — or insights regarding — its emergence or spread.

Prevalence estimation surveys and risk factor studies based on survey (rather than longitudinal) methodology, except when such studies are unique. Surveys of knowledge, attitudes and practices are within scope.

Diagnostic test development if not accompanied by robust sensitivity and specificity estimation from field studies.

Studies focused only on laboratory methods in which relevance to disease emergence and spread is not obvious or can not be inferred (“pure research” type studies).

Narrative literature reviews which do not generate new knowledge. Systematic and scoping reviews, and meta-analyses are within scope.

《跨界和新兴疾病》聚集了对环球植物和人类形成最大经济要挟的沾抱病的最新研讨功效。该期刊为环球有关其诊断、防备和办理的研讨供给了一个平台，也为有关大众卫生、病发机制、风行病学、统计建模、诊断、生物宁静题目、基因组学、疫苗开辟和新疫情疾速传递的论文供给了一个平台。论文应包含利用最早进手艺的实时研讨体例。编辑鼓动勉励论文接纳基于迷信的体例研讨影响这些疾病形成的生物宁静要挟办理的社会经济和环境身分，包含危险阐发和疾病传布建模。将优先斟酌以节制跨界和新兴疾病的新型迷信体例为重点的通信。以下主题凡是被以为超越规模，但会按照详细环境做出决议（比方，对隐藏野生植物种群的研讨和对潜伏物种灭尽的研讨）：

病原体发明：在特定国度新发明的罕见病原体，或一种新的病原体或基因序列，对于其呈现或传布的背景或看法很少。

基于查询拜访（而非纵向）体例的得病率估量查询拜访和危险身分研讨，除非此类研讨是独一无二的。常识、立场和理论查询拜访在规模内。

若是不从实地研讨中取得靠得住的敏理性和特同性估量，则停止诊断测试开辟。

仅存眷尝试室体例的研讨，此中与疾病呈现和传布的相干性不较着或没法揣度（“纯研讨”范例的研讨）。

不会发生新常识的论述性文献综述。系统评估和规模评估和聚集阐发均在规模内。

《Transboundary And Emerging Diseases》(跨界和新发疾病)编辑部通信体例为WILEY-BLACKWELL PUBLISHING, INC, COMMERCE PLACE, 350 MAIN ST, MALDEN, USA, MA, 02148。若是您须要辅佐投稿或润稿办事，您可以或许征询咱们的客服教员。咱们专一于期刊征询办事十年，熟习颁发政策，可为您供给一对一投稿指点，防止您在投稿时频仍碰鼻，节流您的可贵时候，有用晋升颁发机率，确保SCI检索（检索不了全额退款）。咱们视诺言为生命，多方面确保文章宁静失密，在任何环境下都不会泄漏您的小我信息或稿件内容。